West Pharmaceutical Services, Inc. WST
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 29.94% | 15.83% | 16.16% | 0.20% | -1.58% |
| Total Depreciation and Amortization | 11.63% | 11.77% | 10.51% | 10.30% | 9.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -374.03% | 187.67% | -- | 312.50% | -66.45% |
| Change in Net Operating Assets | -685.65% | -641.75% | -161.70% | 2,651.72% | 242.86% |
| Cash from Operations | -5.66% | -2.14% | 7.63% | 15.52% | -1.22% |
| Capital Expenditure | 36.10% | 32.28% | 28.07% | 24.16% | 17.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9,000.00% | -- | -- | -- | 105.26% |
| Cash from Investing | 73.59% | 32.42% | 28.41% | 24.50% | 17.79% |
| Total Debt Issued | -- | -61.45% | -- | -- | -100.00% |
| Total Debt Repaid | -5,622.22% | 61.66% | 99.37% | 99.43% | 99.53% |
| Issuance of Common Stock | 64.07% | 33.16% | 4.93% | -44.34% | -48.93% |
| Repurchase of Common Stock | -260.51% | -87.72% | 30.06% | 75.86% | 72.25% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.46% | -3.83% | -3.69% | -3.55% | -3.58% |
| Other Financing Activities | 87.10% | 87.10% | -110.00% | -110.00% | -- |
| Cash from Financing | -200.04% | -68.26% | 30.45% | 70.27% | 67.40% |
| Foreign Exchange rate Adjustments | -1,357.14% | -191.56% | 242.86% | 207.01% | -95.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -219.48% | -216.38% | 159.31% | 183.05% | 133.75% |